ADR120S Group develops cell therapies using Adipose Derived Regenerative Cells (ADRCs) extracted from patients' own subcutaneous fat tissue via its proprietary Celution device system. The technology enables same-day autologous cell therapy without the need for cell cultivation, avoiding rejection reactions and immunosuppressants. The group also engages in medical asset investment, real estate sales and management through its subsidiaries.
Free demo (no time limit, up to 10 companies). Explore Comps, DCF, LBO, WACC on every screen. Excel export is on the paid plan.
Free Demo (No Time Limit, 10 Companies) →ADR120S Group develops cell therapies using Adipose Derived Regenerative Cells (ADRCs) extracted from patients' own subcutaneous fat tissue via its proprietary Celution device system. The technology enables same-day autologous cell therapy without the need for cell cultivation, avoiding rejection reactions and immunosuppressants. The group also engages in medical asset investment, real estate sales and management through its subsidiaries.
Free demo (no time limit, up to 10 companies). Explore Comps, DCF, LBO, WACC on every screen. Excel export is on the paid plan.
Free Demo (No Time Limit, 10 Companies) →